Funder
Bayer
CMC Microsystems
Merck
Department of Medicine, Georgetown University
Novartis
Daiichi-Sankyo
Roche
Medizinische Universität Wien
Astellas Pharma US
Servier
Meso Scale Diagnostics
Eli Lilly and Company
Pfizer
Amgen
Bristol-Myers Squibb
AbbVie
Reference39 articles.
1. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Kamangar;Lancet Gastroenterol Hepatol,2020
2. Global incidence and mortality of gastric cancer, 1980-2018;Wong;JAMA Netw Open,2021
3. Gastrointestinal cancers in China, the USA, and Europe;Xie;Gastroenterol Rep,2021
4. Global burden of oesophageal and gastric cancer by histology and subsite in 2018;Arnold;Gut,2020
5. Asian ethnicity–related differences in gastric cancer presentation and outcome among patients treated at a Canadian Cancer Center;Gill;J Clin Oncol,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献